08.01.24 -- Bacterial Endotoxin Testing, Part 2: Conducting A Gel Clot LAL Test

Some manufacturers still have reservations about adopting X-ray inspection as a safe method of product inspection. Explore the potential effects of X-ray inspection on pharmaceutical products and more.

As critical raw materials for viral vector production, plasmids are in high demand. Finding an experienced, GMP-grade plasmid supplier for your process can mitigate risk and yield reliable results.

Increased demand for protein delivery and the emergence of advanced modalities – including mRNA – are introducing new challenges to the development lifecycle, such as high-concentration formulations.

Throughout the pandemic, painkiller and sedative demands spiked. Drug manufacturers and CDMOs have become critical in efforts to stabilize the supply of Bupivacaine HCl and other essential drugs.

Lonza principle scientist Deanna Mudie Ph.D. covers the design of dissolution media to support biopredictive dissolution testing and how the properties of a drug and formulation affect performance.

What is tabletability, and why is it important for creating tablets that can survive the journey from manufacturing to packaging?

Explore unexpected operational technology (OT) vulnerability assessment findings, answers to common questions about OT vulnerability assessments and pentesting, and more.

Discover the power of headspace gas ingress in ensuring product quality. Dr. Derek Duncan, Director of Product Lines, Lighthouse Instruments, reveals the golden tool for container closure integrity testing.

Gain insight into one possible test set-up to dilute a product in isopropyl myristate, filter it, and rinse the membrane to eliminate residues that may inhibit microbial growth.

The development and production of CGTs present unparalleled complexities. Learn how a partner with robust end-to-end services can help you overcome challenges at every step of the drug lifecycle.